A multilevel, navigation-based intervention led to more timely initiation of postoperative radiation therapy vs. usual ...
Suggested remit: To appraise the clinical and cost effectiveness of pembrolizumab with olaparib within its marketing authorisation as maintenance treatment of advanced squamous non-small-cell lung ...
Medical Xpress on MSN8d
Computer model simplifies immune cell identification for lung cancer treatmentResearchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...
The number of lung cancer diagnoses amongst people who have never smoked is increasing globally, according to the World ...
New Delhi: Drug major Glenmark Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback